RxDoctor Payments Data

Dennis Thomas, MD

Family Medicine · Quinton, VANPI 1730186883

Payments from drug & device makers

$12,497in general payments, 2019–2025

Across 786 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$2K
  • AbbVie$2K
  • Pfizer$1K
  • Lilly USA, LLC$561
  • Amgen$450
  • plus $5K from 40 others

What the payments were for

  • Food & beverage$12,465100%
  • Education$180%
  • Entertainment$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,497 in reported general payments places this provider in the 95th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$473,255
Medicare patients
1,154
Services billed
13,102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide135$133,044
FarxigaDapagliflozin Propanediol117$127,609
JardianceEmpagliflozin85$122,298
Enbrel SureclickEtanercept13$99,873
JanuviaSitagliptin Phosphate47$63,393
EliquisApixaban49$57,155
XareltoRivaroxaban22$30,834
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$24,967
MounjaroTirzepatide12$23,088
TrulicityDulaglutide11$19,370
Janumet XrSitagliptin Phos/Metformin Hcl18$16,857
NexletolBempedoic Acid21$11,100
Lantus SolostarInsulin Glargine,hum.Rec.Anlog51$9,800
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,764
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$6,739

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$1,790$134,373128 claims
Novo NordiskOzempic$2,099$133,044135 claims
Boehringer IngelheimJardiance$433$122,29885 claims
MerckJanuvia, Janumet Xr$130$80,25065 claims
PfizerEliquis$1,108$57,15549 claims
Lilly USA, LLCMounjaro, Trulicity$561$42,45823 claims
Johnson & JohnsonXarelto$183$30,83422 claims
GSKTrelegy Ellipta$430$24,96723 claims
Esperion Therapeutics, Inc.Nexletol$124$11,10021 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$31$2,903249 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Quinton

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →